home.social

#tumorimmunology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #tumorimmunology, aggregated by home.social.

fetched live
  1. Sharing a new data visualization exploring the phenotypic reprogramming of exhausted CD8+ T cells following PD-1 axis blockade.

    #TcellExhaustion #CheckpointBlockade #TumorImmunology #CD8Tcells #AntiPD1 #Tpex #ImmuneCheckpoint #CancerImmunotherapy

  2. New Visualization: PD-1 Surface Expression Across CD8+ TIL Differentiation States

    I am sharing a violin-style visualization intended to communicate a well-established mechanistic trend in tumor immunology.

    #TumorImmunology #TCellExhaustion #DataVisualization #PD1 #FlowCytometry

  3. Sharing a visualization from a conceptual synthesis of the CD8+ T cell terminal exhaustion (Tex) program in tumor-infiltrating lymphocytes.

    Figure: "Transcriptional and Epigenetic Architecture of CD8+ T Cell Exhaustion"

    #TcellExhaustion #TumorImmunology #CD8Tcells #Epigenetics

  4. T-cells are a major factor in #tumor control, however their diversity makes them a challenging object for quantitative analysis. This new preprint shows a #quantitative toolbox of free open-source tools in action. #AdaptiveImmunity #TumorImmunology #Tcells #cancer #lymphocytes #lymphNodes #TCR
    doi.org/10.64898/2026.06.05.73

  5. 'They identified the 11 most frequently occurring CD4TCRs in mice bearing an autochthonous tumor line. Three TCRs showed evidence of convergent evolution, because T cell clonotypes had different nucleotide sequences but identical TCR α and β chains.'
    #Immunology #TumorImmunology #Immunology
    science.org/doi/10.1126/sciimm

  6. "Here, we developed an approach to reprogram tumor cells in vivo by adenoviral delivery of the transcription factors PU.1, IRF8, and BATF3, which enabled them to present antigens as type 1 conventional dendritic cells"

    #Immunology #TumorImmunology #Immunotherapy

    science.org/doi/10.1126/scienc

  7. 'Here, we analyzed clinical cell and tissue specimens derived from patients presenting with glioblastoma or nonmalignant intracranial disease to report that the cranial bone (CB) marrow, in juxtaposition to treatment-naive glioblastoma tumors, harbors active lymphoid populations at the time of initial diagnosis'
    #Immunology #TumorImmunology

    nature.com/articles/s41591-024

  8. 'We have previously demonstrated that excising transcription factor Kruppel-like factor 2 (Klf2) within the T cell lineage blocks the generation of peripheral-derived Tregs (pTregs) without impairing production of thymic-derived Tregs. Using this mouse model, we have now demonstrated that eliminating pTregs is sufficient to delay/prevent tumor malignancy without causing autoimmunity.'
    #Immunology #TumorImmunology #Tregs #Immunotherapy

    pnas.org/doi/10.1073/pnas.2404

  9. "Together, our data indicate that GLUT10 is selectively required for glucose uptake of CD8+ T cells and identify that TME accumulated lactic acid inhibits CD8+ T cell effector function by directly binding to GLUT10 and reducing its glucose transport capacity. Last, our study suggests disrupting lactate-GLUT10 binding as a promising therapeutic strategy to enhance CD8+ T cell–mediated antitumor effects."
    #Immunology #TumorImmunology #Immunotherapy science.org/doi/10.1126/scitra

  10. 'Late tumors repressed antitumor immunity genes, reducing infiltrating immune cells & tumor–immune cell communications. Innate immune genes, especially interferon-stimulated genes, dominated the list of downregulated tumor genes'

    #Immunology #TumorImmunology #Immunotherapy

    nature.com/articles/s41590-024

  11. 'The T cell landscape in cancer is well characterized, but the contribution of B cells to anticancer immunosurveillance is less well explored. Here we show an integrative analysis of the B cell and T cell receptor repertoire from individuals with metastatic breast cancer and individuals with early breast cancer during neoadjuvant therapy.'

    #Immunology #TumorImmunology

    nature.com/articles/s41590-024

  12. 'Herein, we describe a synapse formation between α-SMA+ CAFs and regulatory T cells (Tregs) in the TME. Foxp3+ Tregs were localized close to α-SMA+CAFs in diverse types of tumor models as well as biopsies from melanoma and colorectal cancer patients.'

    #Immunology #TumorImmunology

    biorxiv.org/content/10.1101/20

  13. 'Here, we use photo-labeling, combined with longitudinal transcriptomic and cellular analyses, to interrogate the fate of intratumoral NK cells. We reveal that NK cells rapidly lose effector functions and adopt a distinct phenotypic state with features associated with tissue residency.'
    #Immunology #TumorImmunology #immunotherapy

    nature.com/articles/s41467-024

  14. "Chronic viral infections are known to accelerate immune aging and to induce immune senescence (21, 22). We have shown that among 206 viruses with human tropism, only CMV seropositivity was associated with senescence of CD8+ T cells in patients with aNSCLC."
    #Immunology #TumorImmunology #Immunotherapy

    science.org/doi/full/10.1126/s

  15. "Animals lacking microglia show increased metastasis, decreased survival and reduced natural killer and T cell responses, showing that microglia are critical to promote anti-tumour immunity to suppress breast cancer brain metastasis."
    #Immunology #TumorImmunology #Microglia

    nature.com/articles/s41556-023

  16. 'A single intramuscular injection of Lenti-HPV-07 into mice bearing established HPV-induced tumors resulted in complete tumor eradication in 100% of the animals and was also effective against lung metastases.'
    #TumorImmunology #Immunology #immunotherapy
    Douguet et al @EmboMolMed

    embopress.org/doi/full/10.1525

  17. 'Here, we show in multiple cancer models that CXCR3+ Treg cells were increased in tumors compared with lymphoid tissues, exhibited an activated phenotype, and interacted preferentially with CXCL9-producing BATF3+ dendritic cells (DCs). Genetic ablation of CXCR3 in Treg cells disrupted DC1-Treg cell interactions and concomitantly increased DC-CD8+ T cell interactions.'

    #Immunology #TumorImmunology #immunotherapy

    cell.com/immunity/fulltext/S10

  18. When discussing the role of microbiome in modulating immune responses to tumours, I did not expect that to require the actual bacteria translocating to the tumour!

    #TumorImmunology #medicine #immunity #immunology #melanoma
    @cellpress
    cell.com/cell/fulltext/S0092-8

  19. Cool work from Michael Fischbach & collaborators: engineering skin bacteria to express tumoral antigens induces protective T cell responses - including at distal sites (in mice).
    #immunology #immunotherapy #TumorImmunology

    science.org/doi/10.1126/scienc

  20. 'Thus, identifying the subset of patients for whom public neoantigens are relevant targets is a major challenge. Nevertheless, the ability provided by the expansion of standard-of-care next-generation sequencing to screen patients affords the opportunity for off-the-shelf precision immunotherapies against public neoantigens that would be broadly applicable to many patients and would have tremendous advantages in scalability relative to targeting private neoantigens'
    #Immunology #Immunotherapy #TumorImmunology

    nature.com/articles/s43018-021

  21. 'In this issue of Nature Medicine, Cascone et al.2share the latest results of their phase 2 platform trial, NEOSTAR, which suggest that the addition of CTLA-4 blockade to neoadjuvant anti-PD-1 plus chemotherapy may augment anti-tumor responses.'

    #LungCancer #Immunology #TumorImmunology #immunotherapy #checkpointinhibitors

    nature.com/articles/s41591-023

  22. "Here, we show that glycolysis drives STING signaling to facilitate DC-mediated antitumor immune responses. Tumor-infiltrating DCs exhibited elevated glycolysis, and blockade of glycolysis by DC-specific Ldha/Ldhb double deletion resulted in defective antitumor immunity."
    #Immunology #TumorImmunology #Immunotherapy #Metabolism
    #InnateImmunity

    jci.org/articles/view/166031

  23. "Thus, we performed a comprehensive screen of TE-chimeric transcripts across 10,357 tumors, 675 cancer cell lines and 11,686 Genotype-Tissue Expression (GTEx) adult tissues, and evaluated these TE-chimeric candidates for tumor specificity, antigenic potential, proteomic validation, HLA presentation and membrane presence."
    #TumorImmunology #immunology

    nature.com/articles/s41588-023

  24. "The induction of cellular cytotoxicity requires that the NK cell contacts its target cell and establishes a lytic immunological synapse. Previous reports have revealed that membrane protrusions may be a component of immune synapses. Here, we explored whether changes in the topology of intratumoral NK cell membranes relate to the formation of lytic immunological synapses."

    #Immunology #TumorImmunology

    nature.com/articles/s41590-023

  25. "Here we show that metabolic conditioning of CD8+ effector T cells induces an oxidized cellular redox balance at least in part mediated by increased mitochondrial reactive oxygen species (ROS). This redox shift contributes to enhanced in vivo persistence and tumor clearance."

    #Preprint #Immunology #metabolism #TumorImmunology

    biorxiv.org/content/10.1101/20

  26. New publication alert in Cancer Discovery (@[email protected]) of a study my colleagues of Lead Pharma and I were involved in! Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha; see aacrjournals.org/cancerdiscove, in cooperation with Avinash Sahu, Xiaoman Wang, @[email protected], @[email protected], Keith Flaherty et al, and my colleagues and me at Lead Pharma. #cancerresearch #cancer #tumorimmunology #targetdiscovery #drugdevelopment #immunometabolism #tumormetabolism

  27. This March the Dutch Society for Immunology (DSI/NVVI) host the NVVI Spring Meeting. We host inspiring talks on many topics in #Immunology: #Infection, #Modeling, #Neuroscience, #Cytokines, #TumorImmunology.
    It's a relatively small meeting, so you have plenty of opportunities to meet the speakers and other participants.

    Early bird registration ends February 16th.

    More information:
    nvvi-dsi.nl/events2/sring-symp

  28. Looking to connect with anybody interested in #tumorimmunology and #invivobiology 👀🤓🐭🧬

Share on Mastodon

Enter the server where you have an account.